Copyright
©The Author(s) 2018.
World J Gastroenterol. Mar 14, 2018; 24(10): 1152-1166
Published online Mar 14, 2018. doi: 10.3748/wjg.v24.i10.1152
Published online Mar 14, 2018. doi: 10.3748/wjg.v24.i10.1152
Figure 5 Alpha-fetoprotein and glypican-3 expression in PGRMC1-knockdown HepG2 and Hep3B cells and PGRMC1-overxpressing PLC/PRF/5 and Huh7 cells (A).
B: The correlation of PGRMC1 with AFP and GPC3 in HCC tissue samples in the TCGA cohort; C: Cell proliferation assay (XTT) of PGRMC1-knockdown HepG2 and Hep3B cells and PGRMC1-overxpressing PLC/PRF/5 and Huh7 cells. The experiment was performed in triplicate. aP < 0.05, bP < 0.01, eP < 0.001. AFP: Alpha-fetoprotein; GPC3: Glypican-3.
- Citation: Tsai HW, Ho CL, Cheng SW, Lin YJ, Chen CC, Cheng PN, Yen CJ, Chang TT, Chiang PM, Chan SH, Ho CH, Chen SH, Wang YW, Chow NH, Lin JC. Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma. World J Gastroenterol 2018; 24(10): 1152-1166
- URL: https://www.wjgnet.com/1007-9327/full/v24/i10/1152.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i10.1152